Article
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.
European urology - 1 Nov 2008
Haese Alexander, de la Taille Alexandre, van Poppel Hendrik, Marberger Michael, Stenzl Arnulf, Mulders Peter F A, Huland Hartwig, Abbou Clément-Claude, Remzi Mesut, Tinzl Martina, Feyerabend Susan, Stillebroer Alexander B, van Gils Martijn P M Q, Schalken Jack A
Abstract excerpt
BACKGROUND: The Prostate CAncer gene 3 (PCA3) assay has shown promise as an aid in prostate cancer (pCA) diagnosis in identifying men with a high probability of a positive (repeat) biopsy. OBJECTIVE: This study evaluated the clinical utility of the PROGENSA PCA3 assay. DESIGN, SETTING, AND PARTICIPANTS: This European prospective, multicentre study enrolled men with one or two negative biopsies scheduled for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
